PharmAbcine, SLBio to evaluate combination therapy to treat NSCLC

Pharma |  News | 0 Comment | 05 Aug, 2020

South Korean firm PharmAbcine Inc. entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to ...Read more

G1, Simcere to bring new cancer therapy in Greater China

Pharma |  News | 0 Comment | 06 Aug, 2020

US based G1 Therapeutics, Inc., a clinical-stage oncology company, and Simcere Pharmaceutical Group, a pharmaceutic...Read more

Takeda announces results for first quarter of fiscal 2020

Pharma |  News | 0 Comment | 03 Aug, 2020

Japan-based Takeda Pharmaceutical Company Limited (Takeda) recently announced financial results for the first quarter of...Read more

Takeda receives U.S. FDA Breakthrough Therapy Designation for Pevonedistat

Pharma |  News | 0 Comment | 30 Jul, 2020

Takeda Pharmaceutical Company Limited on 30 July 2020 announced that the U.S. Food and Drug Administration (FD...Read more

Innovent announces first patient dosed in Ph 1 clinical trial of bispecific antibody

Pharma |  News | 0 Comment | 03 Aug, 2020

Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical Chinese company that develops, manufactures and com...Read more

Novartis to strengthen future of antibiotics manufacturing in Europe

Pharma |  News | 0 Comment | 04 Aug, 2020

Sandoz, the Novartis generics and biosimilars division, is pleased to announce plans for a joint investment, together wi...Read more

J&J to commence Ph III trial of COVID-19 vaccine in Sept

Pharma |  News | 0 Comment | 03 Aug, 2020

American multinational corporation Johnson & Johnson (J&J) has announced that its lead vaccine candidate pr...Read more

Hisun's Favipiravir supports Middle East in fighting COVID-19

Pharma |  News | 0 Comment | 31 Jul, 2020

  According to the Middle East News Agency, Favipiravir, the popular drug used for treating COVID-19 has shown exc...Read more

Henlius & Accord Healthcare receives EMA approval for Zercepac®

Pharma |  News | 0 Comment | 30 Jul, 2020

The European Commission (EC) has approved Shanghai-based Henlius Biotech, Inc. and Accord Healthcare Limited (Accor...Read more

Austrianova files Drug Master File with FDA for Cell-in-a-Box products from HEK293 cells

Pharma |  News | 0 Comment | 28 Jul, 2020

S.E. Asian company, Austrianova, headquartered in Singapore, announced on 28 July 2020 that it has filed a Drug Mas...Read more

A strong signal in turbulent times: Vetter achieves carbon dioxide-neutral levels

Pharma |  News | 0 Comment | 29 Jul, 2020

Focus on energy-efficient and environmentally friendly technology All European sites utilize green electricity Savin...Read more

Dynavax, Medigen to develop adjuvanted COVID-19 vaccine candidate

Pharma |  News | 0 Comment | 30 Jul, 2020

US based Dynavax Technologies Corporation, a biopharmaceutical company focused on developing and commercializing novel v...Read more

Novavax, Fujifilm to manufacture COVID-19 vaccine at large scale

Pharma |  News | 0 Comment | 30 Jul, 2020

US based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious di...Read more

Henlius, Accord receive EMA approval for Zercepac®, trastuzumab biosimilar

Pharma |  News | 0 Comment | 29 Jul, 2020

Shanghai Henlius Biotech, Inc. announced that Marketing Authorization Application (“MAA”) for HLX02 (trastuz...Read more

Foresee announces submission of NDA for FDA approval of LMIS 50 mg

Pharma |  News | 0 Comment | 29 Jul, 2020

Taiwan and US-based biopharmaceutical company, Foresee Pharmaceuticals Co., Ltd. (Foresee), recently announced that...Read more

CPhI Japan announces 2021 postponement

Pharma |  News | 0 Comment | 28 Jul, 2020

CPhI Japan – organised by Informa Markets – announces that, following a detailed review with partners a...Read more

Daiichi Sankyo signs deal with AstraZeneca for $6B

Pharma |  News | 0 Comment | 27 Jul, 2020

Japanese firm Daiichi Sankyo Company, Limited has announced that it has entered into a global development and commercial...Read more

NBQ moves ahead with transformative treatment for brain cancers

Pharma |  News | 0 Comment | 24 Jul, 2020

A Chinese clinical-stage biopharmaceutical company, N.B. Quadriga (NBQ), developing transformative medicines for brain c...Read more